CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Substantial loss of intrahepatic HBV cccDNA during antiviral combination therapy translates into long-term clinical benefit
DOI 10.1055/s-2007-988525
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Lütgehetmann, M Dandri, T Volz, M Zankel, C Fischer, J Petersen
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background/aims: The aim of the study was to determine the virological, serological, and histological outcome, including cccDNA, in chronic Hepatitis B (CH-B) patients after 48 weeks of pegylated interferon (PEG-IFNalpha2b) and adefovir (ADV) combination therapy (year-1-data): Hepatology2006;44:675–684), followed by 96 weeks of ADV mono therapy. Here we report the final analysis of the study after 144 weeks of antiv…
Zitieren
Zitierempfehlung
M Lütgehetmann, M Dandri, T Volz, M Zankel, C Fischer, J Petersen (2007) Substantial loss of intrahepatic HBV cccDNA during antiviral combination therapy translates into long-term clinical benefit. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-2007-988525
Mit CareLit weiterarbeiten